Skip to main content
Notice2026-18200

Stephen Bossenberry, M.D.; Decision and Order

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 8, 2026

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 172 (Tuesday, September 8, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 172 (Tuesday, September 8, 2026)]
[Notices]
[Pages 57163-57164]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18200]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Stephen Bossenberry, M.D.; Decision and Order

    On February 18, 2026, the Drug Enforcement Administration (DEA or 
Government) issued an Order to Show Cause (OSC) to Stephen Bossenberry, 
M.D., of Grand Blanc, Michigan (Registrant). Request for Final Agency 
Action (RFAA), Exhibit (RFAAX) 1, at 1, 3. The OSC proposed the 
revocation of Registrant's Certificate of Registration No. FB7239393, 
alleging that Registrant's registration should be revoked because 
Registrant is ``currently without authority to prescribe, administer, 
dispense, or otherwise handle controlled substances in the State of 
Michigan, the state in which [he is] registered with DEA.'' Id. at 2. 
(citing 21 U.S.C. 824(a)(3)).\1\
---------------------------------------------------------------------------

    \1\ According to Agency records, Registrant's registration 
expired on July 31, 2026. The fact that a registrant allows his 
registration to expire during the pendency of an OSC does not impact 
the Agency's jurisdiction or prerogative under the Controlled 
Substances Act (CSA) to adjudicate the OSC to finality. Jeffrey D. 
Olsen, M.D., 84 FR 68474, 68476-79 (2019).
---------------------------------------------------------------------------

    The OSC notified Registrant of his right to file a written request 
for hearing, and that if he failed to file such a request, he would be 
deemed to have waived his right to a hearing and be in default. Id. 
(citing 21 CFR 1301.43). Here, Registrant did not request a hearing, 
and the Agency finds him to be in default. RFAA, at 2.\2\ ``A default, 
unless excused, shall be deemed to constitute a waiver of the 
registrant's/applicant's right to a hearing and an

[[Page 57164]]

admission of the factual allegations of the [OSC].'' 21 CFR 1301.43(e).
---------------------------------------------------------------------------

    \2\ Based on the Government's submissions in its RFAA dated May 
20, 2026, the Agency finds that service of the OSC on Registrant was 
adequate. The RFAA's included Declaration from a DEA Diversion 
Investigator (DI) indicates that, after discovering that Registrant 
was no longer employed at his DEA registered address, on March 6, 
2026, the DI traveled to the address associated with Registrant's 
Michigan driver's license to attempt personal service of the OSC on 
Registrant, but Registrant was not present at the address. RFAAX 2, 
at 1-2. On March 10, 2026, the DI mailed copies of the OSC to 
Registrant's registered address and Registrant's mailing address, as 
well as emailed the OSC to Registrant's registered email address. 
Id. at 2; see also id., Attachment A. Here, the Agency finds that 
Registrant was successfully served the OSC by email and that the 
DI's efforts to serve Registrant by other means were `` `reasonably 
calculated, under all the circumstances, to apprise [Registrant] of 
the pendency of the action.' '' Jones v. Flowers, 547 U.S. 220, 226 
(2006) (quoting Mullane v. Central Hanover Bank & Trust Co., 339 
U.S. 306, 314 (1950)). Therefore, due process notice requirements 
have been satisfied. See Mohammed S. Aljanaby, M.D., 82 FR 34552, 
34552 (2017) (finding that service by email satisfies due process 
where the email is not returned as undeliverable and other methods 
have been unsuccessful); Emilio Luna, M.D., 77 FR 4829, 4830 (2012) 
(same).
---------------------------------------------------------------------------

    Further, ``[i]n the event that a registrant . . . is deemed to be 
in default . . . DEA may then file a request for final agency action 
with the Administrator, along with a record to support its request. In 
such circumstances, the Administrator may enter a default final order 
pursuant to [21 CFR] 1316.67.'' Id. at 1301.43(f)(1). Here, the 
Government has requested final agency action based on Registrant's 
default pursuant to 21 CFR 1301.43(c), (f), 1301.46. RFAA, at 1; see 
also 21 CFR 1316.67.

Findings of Fact

    The Agency finds that, in light of Registrant's default, the 
factual allegations in the OSC are deemed admitted. According to the 
OSC, on December 20, 2025, both Registrant's Michigan medical license 
and Michigan controlled substance license expired by their own terms. 
RFAAX 1, at 2. According to Michigan online records, of which the 
Agency takes official notice,\3\ both Registrant's Michigan medical 
license and Michigan controlled substance license remain expired. State 
of Michigan Licensing & Regulatory Affairs Professional Licensing 
Search, <a href="https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx">https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx</a> (last visited date of signature of this Order). 
Accordingly, the Agency finds that Registrant is not licensed to 
practice medicine nor to handle controlled substances in Michigan, the 
state in which he is registered with DEA.\4\
---------------------------------------------------------------------------

    \3\ Under the Administrative Procedure Act, an agency ``may take 
official notice of facts at any stage in a proceeding--even in the 
final decision.'' United States Department of Justice, Attorney 
General's Manual on the Administrative Procedure Act 80 (1947) (Wm. 
W. Gaunt & Sons, Inc., Reprint 1979).
    \4\ Pursuant to 5 U.S.C. 556(e), ``[w]hen an agency decision 
rests on official notice of a material fact not appearing in the 
evidence in the record, a party is entitled, on timely request, to 
an opportunity to show the contrary.'' The material fact here is 
that Registrant, as of the date of this Order, is not licensed to 
practice medicine nor to handle controlled substances in Michigan. 
Accordingly, Registrant may dispute the Agency's finding by filing a 
properly supported motion for reconsideration of findings of fact 
within fifteen calendar days of the date of this Order. Any such 
motion and response shall be filed and served by email to the other 
party and to the Office of the Administrator, Drug Enforcement 
Administration, at <a href="/cdn-cgi/l/email-protection#9efafbffb0fffafaf1b0ffeaeaf1ecf0fbe7eddefafbffb0f9f1e8"><span class="__cf_email__" data-cfemail="d2b6b7b3fcb3b6b6bdfcb3a6a6bda0bcb7aba192b6b7b3fcb5bda4">[email&#160;protected]</span></a>.
---------------------------------------------------------------------------

Discussion

    Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized 
to suspend or revoke a registration issued under 21 U.S.C. 823 ``upon a 
finding that the registrant . . . has had his State license or 
registration suspended . . . [or] revoked . . . by competent State 
authority and is no longer authorized by State law to engage in the . . 
. dispensing of controlled substances.'' With respect to a 
practitioner, DEA has also long held that the possession of authority 
to dispense controlled substances under the laws of the state in which 
a practitioner engages in professional practice is a fundamental 
condition for obtaining and maintaining a practitioner's registration. 
Gonzales v. Oregon, 546 U.S. 243, 270 (2006) (``The Attorney General 
can register a physician to dispense controlled substances `if the 
applicant is authorized to dispense . . . controlled substances under 
the laws of the State in which he practices.' . . . The very definition 
of a `practitioner' eligible to prescribe includes physicians 
`licensed, registered, or otherwise permitted, by the United States or 
the jurisdiction in which he practices' to dispense controlled 
substances. 802(21).''). The Agency has applied these principles 
consistently. See, e.g., Lawrence Rudolph, D.M.D., 89 FR 79310 (2024); 
Henry-Norbert O. Ndekwe, M.D., 90 FR 15990 (2025); Benson Sergiles, 
P.A., 90 FR 32016 (2025).\5\
---------------------------------------------------------------------------

    \5\ This rule derives from the text of two provisions of the 
CSA. First, Congress defined the term ``practitioner'' to mean ``a 
physician . . . or other person licensed, registered, or otherwise 
permitted, by . . . the jurisdiction in which he practices . . . , 
to distribute, dispense, . . . [or] administer . . . a controlled 
substance in the course of professional practice.'' 21 U.S.C. 
802(21). Second, in setting the requirements for obtaining a 
practitioner's registration, Congress directed that ``[t]he Attorney 
General shall register practitioners . . . if the applicant is 
authorized to dispense . . . controlled substances under the laws of 
the State in which he practices.'' 21 U.S.C. 823(g)(1). Because 
Congress has clearly mandated that a practitioner possess state 
authority in order to be deemed a practitioner under the CSA, DEA 
has held repeatedly that revocation of a practitioner's registration 
is the appropriate sanction whenever he is no longer authorized to 
dispense controlled substances under the laws of the state in which 
he practices. See, e.g., Elias Garcia Garcia, P.A., 90 FR 31242 
(2025); Jason Weakley, R.N., A.P.R.N., 90 FR 10085 (2025); Khursheed 
Haider, M.D., 90 FR 21950 (2025).
---------------------------------------------------------------------------

    According to Michigan law, ``a person who manufactures, 
distributes, prescribes, or dispenses a controlled substance in this 
state or who proposes to engage in the manufacture, distribution, 
prescribing, or dispensing of a controlled substance in this state 
shall obtain a license issued by the [Michigan Board of Pharmacy] in 
accordance with the rules.'' Mich. Comp. Laws Sec.  333.7303(1) (2025).
    Here, the undisputed evidence in the record is that Registrant 
lacks authority to handle controlled substances in Michigan because his 
Michigan controlled substance license is expired. As discussed above, 
an individual must hold a Michigan controlled substance license to 
dispense controlled substances in Michigan. Thus, because Registrant 
lacks authority handle controlled substances in Michigan, Registrant is 
not eligible to maintain a DEA registration. Accordingly, the Agency 
will order that Registrant's DEA registration be revoked.

Order

    Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. 
FB7239393 issued to Stephen Bossenberry, M.D. Further, pursuant to 28 
CFR 0.100(b) and the authority vested in me by 21 U.S.C. 823(g)(1), I 
hereby deny any pending applications of Stephen Bossenberry, M.D., to 
renew or modify this registration, as well as any other pending 
application of Stephen Bossenberry, M.D., for additional registration 
in Michigan. This Order is effective October 8, 2026.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
August 31, 2026, by DEA Administrator Terrance C. Cole. That document 
with the original signature and date is maintained by DEA. For 
administrative purposes only, and in compliance with requirements of 
the Office of the Federal Register, the undersigned DEA Federal 
Register Liaison Officer has been authorized to sign and submit the 
document in electronic format for publication, as an official document 
of DEA. This administrative process in no way alters the legal effect 
of this document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2026-18200 Filed 9-4-26; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on September 8, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.